{ "@context": "http:\/\/schema.org", "@type": "Article", "image": "https:\/\/sandiegouniontribune.sergipeconectado.com\/wp-content\/s\/2025\/03\/SUT-L-NEFFY-FDA-0307-01.jpg?w=150&strip=all", "headline": "San Diego biotech gets FDA approval for EpiPen alternative for kids", "datePublished": "2025-03-06 16:06:09", "author": { "@type": "Person", "workLocation": { "@type": "Place" }, "Point": { "@type": "Point", "Type": "Journalist" }, "sameAs": [ "https:\/\/sandiegouniontribune.sergipeconectado.com\/author\/gqlshare\/" ], "name": "gqlshare" } } Skip to content
Business | San Diego biotech gets FDA approval for EpiPen…
61°F
Thursday, June 12th 2025

e-Edition

Trending:

Business

San Diego biotech gets FDA approval for EpiPen alternative for kids

The newly approved dosage of epinephrine nasal spray, Neffy, is geared toward children as young as 4

San Diego-based ARS Pharmaceuticals received FDA approval for its 1 milligram dose of Neffy, an epinephrine nasal spray. The new dose is geared toward patients as young as 4. (ARS Pharmaceuticals)
San Diego-based ARS Pharmaceuticals received FDA approval for its 1 milligram dose of Neffy, an epinephrine nasal spray. The new dose is geared toward patients as young as 4. (ARS Pharmaceuticals)
By | [email protected] | The San Diego Union-Tribune
UPDATED:

The newly approved dosage of epinephrine nasal spray, Neffy, is geared toward children as young as 4.

Subscribe to continue reading this article.

Already subscribed? To , click here.

Originally Published:

RevContent Feed

More in Business

Events